| Revenue growth | Flat YoY at ₹4300cr for FY26. |
|---|---|
| Margins | Structural margins improved by 100bps; net margin up ~200bps over 10Y. |
| Demand visibility | Muted sales; rural consumption softening due to inflation. |
| Management confidence | High; focusing on long-term value via Integrated Growth Strategy. |
Growth
PAT grew 19% YoY to ₹850cr; sales flat at ₹4300cr. 10-year CAGR: sales doubled, profit doubled.
Outlook
Targeting mid-to-high single-digit category growth. Multi-year productivity program delivered ₹86cr savings in FY26.
Risks
Inflation in commodities (crude/resin up 30-50%), media fragmentation, and West Asia conflict impacting supply chain costs.
Last quarter's promises, checked
Delivered
- Guided 9-month sales Rs 3374cr → delivered FY26 Rs 4300cr (= BEAT)
- Guided net margin improvement ~60bps → delivered structural margin up 100bps (= BEAT)
- Guided productivity savings Rs 93cr → delivered Rs 86cr in FY26 (= BEAT)
Partly delivered
- Guided rural demand recovery → delivered muted sales and rural softening (= PARTIAL)
Missed
- Guided 3% sales growth momentum → delivered flat YoY sales (= MISS)
Earnings Call filed with BSE, NSE: PGHH. Summary written with AI assistance from the document.
Procter & Gamble Hygiene & Healthcare Ltd: key numbers
- Share price
- ₹6,909.00
- Market cap
- ₹22,427 Cr
- Revenue (annual)
- ₹4,290 Cr
- Net profit (annual)
- ₹856.5 Cr
- P/E (TTM)
- 28.4×Sector 42.5×
- Promoter holding
- 70.64%+0.00% QoQ
- FII holding
- 0.98%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Procter & Gamble Hygiene & Healthcare Ltd
All →Procter & Gamble Hygiene & Healthcare Board Meeting Date
P&G Hygiene and Health Care will hold a board meeting on November 12, 2026, to consider unaudited standalone financial results for the half-year ending September 2026.
Procter & Gamble Hygiene & Healthcare Management Change
Procter & Gamble Hygiene and Health Care Limited has appointed Ms. Flavia Machado as Company Secretary and Compliance Officer, effective September 29, 2026.
Procter & Gamble Hygiene & Healthcare Price Movement Clarification
P&G Hygiene and Health Care denied baseless rumors of potential delisting or winding up. Filed under Reg 30(11) due to material price movement.
Procter & Gamble Hygiene & Healthcare Management Change
P&G Hygiene and Health Care announced appointment of Ms. Srividya Srinivasan as Whole-time Director effective July 1, 2026. Shareholders approved the five-year term at the 62nd AGM on September 8, 2026.
Procter & Gamble Hygiene & Healthcare Annual General Meeting
Procter & Gamble Hygiene and Health Care Ltd held its 62nd Annual General Meeting on September 8, 2026, to discuss financial statements, dividends, and director appointments.
Procter & Gamble Hygiene & Healthcare Business Update
Procter & Gamble Hygiene and Health Care Ltd has released its Business Responsibility and Sustainability Report for the financial year ended March 31, 2026. This filing details the company's performance on ESG metrics.